Bismuth Quadruple Therapy Versus Standard Triple Therapy
Status:
Recruiting
Trial end date:
2025-11-03
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the standard triple therapy with Bismuth
quadruple therapy in children infected with Helicobacter pylori.
The main questions to answer are:
- the safety
- the efficacy of the quadruple protocol with Bismuth subcitrate
Participants will be randomised in 7-days eradication therapy group and 14-days eradication
control group.